Skip to main contentSkip to navigation
Sirius Investors
Hadasit Bio-Holdings Ltd

Hadasit Bio-Holdings Ltd

HSITF
OTCHealthcare

Hadasit Bio-Holdings Ltd (HSITF) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Hadasit Bio-Holdings Ltd's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2024
P/E Ratio
-1.41
Burn Risk
P/B Ratio
2.99
Strong
WeakModerateStrong
Earnings Yield
-71.63%
Yield Gap

Profitability Health

2024
Return on Equity
-214.17%
Weak
WeakModerateStrong
Operating Margin
-
No data
Net Profit Margin
-
No data

Growth Indicators

2024
Revenue Growth
-
No data
Net Income Growth
88.14%
Strong
WeakModerateStrong
EPS Growth
88.21%
Strong
WeakModerateStrong

Efficiency & Liquidity

2024
Current Ratio
4.44
Strong
WeakModerateStrong
Quick Ratio
4.44
Strong
WeakModerateStrong
Asset Turnover
-
No data
Inventory Turnover
-
No data

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2024
Free Cash Flow Yield
-34.85%
Weak
WeakModerateStrong
EV / Free Cash Flow
-2.35x
Strong
WeakModerateStrong
Net Debt / EBITDA
0.51x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
2.374
Strong
WeakModerateStrong
Return on Invested Capital
-72.76%
Weak
WeakModerateStrong
Cash Conversion Cycle
0.00 days
Strong
WeakModerateStrong

Fortress screener guardrails

1/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for HSITF.

View Financial Statements